Tomas Adomavicius

Tomas Adomavicius is a Senior Protein Scientist at Peak Proteins since March 2020, with prior experience as a Senior Scientist at AstraZeneca and as a Research Associate and PhD Student at The University of Manchester. Research activities included the development of a new malaria vaccine candidate based on a virus-like particle and a malarial epitope. Earlier experience includes a part-time internship at Fermentas UAB focused on screening effective DNA polymerase mutants. Academic credentials include a PhD in Structural Biology and an MSc in Biochemistry from The University of Manchester, as well as a BSc in Biochemistry from Vilnius University.